Lubricity Post-Wear - Competitive Lenses Pilot

NCT ID: NCT02402127

Last Updated: 2016-09-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to measure the coefficient of friction of three silicone hydrogel, daily disposable contact lenses after 16 hours of wear.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this 3-treatment, 3-period, 6-sequence crossover study, each participant will wear all 3 products in randomized order, 1 product at a time, with a washout period of up to 7 days between treatment periods. Lenses will be collected for ex-vivo lubricity analysis. The ex-vivo lubricity analysis will be conducted under a separate non-clinical protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Error

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TruEye, MyDay, clariti 1day

Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

TruEye, clariti 1day, MyDay

Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

MyDay, TruEye, clariti 1day

Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

MyDay, clariti 1day, TruEye

Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Clariti 1day, TruEye, MyDay

Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Clariti 1day, MyDay, TruEye

Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Group Type OTHER

Narafilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Stenfilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Somofilcon A contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses for daily disposable wear

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Narafilcon A contact lenses

Silicone hydrogel contact lenses for daily disposable wear

Intervention Type DEVICE

Stenfilcon A contact lenses

Silicone hydrogel contact lenses for daily disposable wear

Intervention Type DEVICE

Somofilcon A contact lenses

Silicone hydrogel contact lenses for daily disposable wear

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

1-DAY ACUVUE® TruEye® (TruEye) MyDay™ clariti® 1day

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must sign an informed consent form.
* Soft contact lens wearer (both eyes).
* Willing to wear study lenses at least 16 waking hours and attend all study visits.

Exclusion Criteria

* Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
* Use of systemic or ocular medications for which contact lens wear could be contraindicated.
* Use of artificial tears and rewetting drops during the study.
* Monocular (only 1 eye with functional vision) or fit with only 1 lens.
* History of herpetic keratitis, ocular surgery, or irregular cornea.
* Pregnant.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Manager, Vision Care, Global Medical Affairs

Role: STUDY_DIRECTOR

Alcon Research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLT567-P001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.